Valsartan Disodium Hydrate is an angiotensin II receptor antagonist utilized in the treatment of high blood pressure, heart failure, and diabetic kidney disease by inhibiting the effects of angiotensin… Read more
Valsartan Disodium Hydrate is an angiotensin II receptor antagonist utilized in the treatment of high blood pressure, heart failure, and diabetic kidney disease by inhibiting the effects of angiotensin II on vascular smooth muscle. Laboratories requiring accurate analytical testing rely on high-quality reference standards of Valsartan Disodium Hydrate, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, to ensure precision in method development. These compounds are essential for rigorous impurity profiling and method validation, facilitating reliable quality control assessments. By providing consistent standards for these specific chemical derivatives, researchers and analytical chemists can maintain regulatory compliance and support the integrity of pharmaceutical testing protocols required for assessing the safety and efficacy of therapeutic compounds.